Economy
-
-
WTW lands global deal with Zurich Insurance to expand Radar deployment
-
Rothschild Redburn initiates Hut 8 stock with neutral rating
-
Rothschild Redburn initiates IREN stock with neutral rating
-
Poland’s August corporate wages rise 5.6%, miss forecasts
-
Euro zone yields ease as markets await of ECB’s Lagarde speech
-
Why is Elixirr International stock tumbling today?
-
China’s Xi to visit the US from September 23-25
-
Craneware shares plunge 23% after cyber incident, weaker outlook
-
Moderna’s Bob Langer and AI pioneer Yann LeCun join board of Cellular Intelligence, bringing AI into medicine via a Parkinson’s drug
Cellular Intelligence is trying to build an AI model that can predict and eventually control how living cells behave, the same way AI models predict text or images, in hopes of making new medicines faster and cheaper to develop. The company took a step toward that goal Monday, announcing that Moderna co-founder Robert “Bob” Langer…